I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
- Written by PR Newswire
![]() |
ROCKVILLE, Md., June 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer....
Read more: I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer















